{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T14:19:47Z","timestamp":1791814787356,"version":"4.3.4"},"reference-count":45,"publisher":"Oxford University Press (OUP)","issue":"8","license":[{"start":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T00:00:00Z","timestamp":1786492800000},"content-version":"vor","delay-in-days":11,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100006095","name":"South-Eastern Norway Regional Health Authority","doi-asserted-by":"publisher","award":["2023090"],"award-info":[{"award-number":["2023090"]}],"id":[{"id":"10.13039\/501100006095","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,8,5]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background and Aims<\/jats:title>\n                    <jats:p>Monoclonal antibodies against tumor necrosis factor (anti-TNF) are effective agents in the treatment of moderate-to-severe ulcerative colitis (UC). It is unclear whether such treatment can safely be discontinued without relapse. This study aimed to identify biomarkers to predict which patients can successfully stop anti-TNF treatment, and to increase our understanding of the pathogenesis of relapse after withdrawal and flare on continued therapy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We analyzed longitudinal bulk RNA-sequencing data derived from rectal mucosal biopsies from 163 patients in the BIOSTOP study collected at baseline, after 2\u2009years (end of study), and at flares or relapse points.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>In this cohort, pre-withdrawal transcriptomic profiles did not distinguish patients who later relapsed from those who remained in long-term remission. Longitudinal analysis of patients who relapsed or flared were both characterized by inflammatory gene expression profiles (eg, CXCL9, CXCL10, OSMR, SELE) and changes in cell-type composition typical for active UC (eg, monocytes\/macrophages and THY1+ FAP+ PDPN+ activated fibroblasts). Both groups showed enrichment of T-cell-associated transcriptional signatures, including CD8 T-cell-related genes and IL-17-associated pathways. Additionally, both patient groups showed increased expression of targets of alternative therapeutic agents, suggesting potential treatment options for specific patient subgroups.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Our findings provide insights into the inflammatory mechanisms driving relapse after anti-TNF withdrawal and flare on continued treatment. The dataset offers a valuable resource for future research to improve personalized treatment strategies in UC.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/ecco-jcc\/jjag121","type":"journal-article","created":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T11:54:56Z","timestamp":1784807696000},"source":"Crossref","is-referenced-by-count":1,"title":["Longitudinal transcriptomic analysis of mucosa in ulcerative colitis after anti-tumor necrosis factor withdrawal compared to continued treatment"],"prefix":"10.1093","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-4980-7066","authenticated-orcid":false,"given":"Emma","family":"Rapp","sequence":"first","affiliation":[{"name":"Department of Pathology, Oslo University Hospital , 0372 Oslo,","place":["Norway"]},{"name":"Institute of Clinical Medicine, University of Oslo , 0450 Oslo,","place":["Norway"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2014-8497","authenticated-orcid":false,"given":"Ingrid Prytz","family":"Berset","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, M\u00f8re & Romsdal Hospital Trust , 6017 \u00c5lesund,","place":["Norway"]},{"name":"Norwegian Coeliac Disease Research Centre, University of Oslo , 0372 Oslo,","place":["Norway"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8081-7819","authenticated-orcid":false,"given":"Sinan U","family":"Umu","sequence":"additional","affiliation":[{"name":"Department of Pathology, Oslo University Hospital , 0372 Oslo,","place":["Norway"]},{"name":"Institute of Clinical Medicine, University of Oslo , 0450 Oslo,","place":["Norway"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Espen S\u00f8nderaal","family":"B\u00e6kkevold","sequence":"additional","affiliation":[{"name":"Department of Pathology, Oslo University Hospital , 0372 Oslo,","place":["Norway"]},{"name":"Institute of Oral Biology, University of Oslo , 0372 Oslo,","place":["Norway"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Sivertsen Utheim","sequence":"additional","affiliation":[{"name":"Institute of Clinical Medicine, University of Oslo , 0450 Oslo,","place":["Norway"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8661-0453","authenticated-orcid":false,"given":"Alexander","family":"Dietrich","sequence":"additional","affiliation":[{"name":"Data Science in Systems Biology, TUM School of Life Sciences, Technical University of Munich , 85354 Freising,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0941-4168","authenticated-orcid":false,"given":"Markus","family":"List","sequence":"additional","affiliation":[{"name":"Data Science in Systems Biology, TUM School of Life Sciences, Technical University of Munich , 85354 Freising,","place":["Germany"]},{"name":"Munich Data Science Institute (MDSI), Technical University of Munich , 85748 Garching,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kjersti","family":"Thorvaldsen Hagen","sequence":"additional","affiliation":[{"name":"Institute of Clinical Medicine, University of Oslo , 0450 Oslo,","place":["Norway"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2243-8882","authenticated-orcid":false,"given":"Frode","family":"Lerang","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, \u00d8stfold Hospital Trust , 1714 Gr\u00e5lum, Sarpsborg,","place":["Norway"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7861-2125","authenticated-orcid":false,"given":"Dag Arne Lihaug","family":"Hoff","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, M\u00f8re & Romsdal Hospital Trust , 6017 \u00c5lesund,","place":["Norway"]},{"name":"Department of Health Sciences, Norwegian University of Science and Technology , 6009 \u00c5lesund,","place":["Norway"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Knut E A","family":"Lundin","sequence":"additional","affiliation":[{"name":"Institute of Clinical Medicine, University of Oslo , 0450 Oslo,","place":["Norway"]},{"name":"Norwegian Coeliac Disease Research Centre, University of Oslo , 0372 Oslo,","place":["Norway"]},{"name":"Department of Gastroenterology, Oslo University Hospital, Rikshospitalet , 0372 Oslo,","place":["Norway"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frode Lars","family":"Jahnsen","sequence":"additional","affiliation":[{"name":"Department of Pathology, Oslo University Hospital , 0372 Oslo,","place":["Norway"]},{"name":"Institute of Clinical Medicine, University of Oslo , 0450 Oslo,","place":["Norway"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana","family":"Domanska","sequence":"additional","affiliation":[{"name":"Department of Pathology, Oslo University Hospital , 0372 Oslo,","place":["Norway"]},{"name":"Faculty of Mathematics and Computer Science, University of Warmia and Mazury in Olsztyn , 10-710 Olsztyn,","place":["Poland"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,8,12]]},"reference":[{"key":"2026081219452678000_jjag121-B1","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1016\/S0140-6736(23)00966-2","article-title":"Ulcerative colitis","volume":"402","author":"Le Berre","year":"2023","journal-title":"Lancet"},{"key":"2026081219452678000_jjag121-B2","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1038\/s41572-020-0205-x","article-title":"Ulcerative colitis","volume":"6","author":"Kobayashi","year":"2020","journal-title":"Nat Rev Dis Primers"},{"key":"2026081219452678000_jjag121-B3","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1016\/j.crohns.2013.01.010","article-title":"The burden of inflammatory bowel disease in Europe","volume":"7","author":"Burisch","year":"2013","journal-title":"J Crohns Colitis"},{"key":"2026081219452678000_jjag121-B4","doi-asserted-by":"publisher","first-page":"s1","DOI":"10.1136\/gutjnl-2024-334395","article-title":"British Society of Gastroenterology guidelines on inflammatory bowel disease in adults: 2025","volume":"74","author":"Moran","year":"2025","journal-title":"Gut"},{"key":"2026081219452678000_jjag121-B5","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1093\/ecco-jcc\/jjab178","article-title":"ECCO guidelines on therapeutics in ulcerative colitis: medical treatment","volume":"16","author":"Raine","year":"2022","journal-title":"J Crohns Colitis"},{"key":"2026081219452678000_jjag121-B6","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1136\/gutjnl-2019-320022","article-title":"25 years of anti-TNF treatment for inflammatory bowel disease: lessons from the past and a look to the future","volume":"70","author":"D\u2019Haens","year":"2021","journal-title":"Gut"},{"key":"2026081219452678000_jjag121-B7","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1093\/ecco-jcc\/jjad203","article-title":"Biologic therapy for inflammatory bowel disease: real-world comparative effectiveness and impact of drug sequencing in 13 222 patients within the UK IBD BioResource","volume":"18","author":"Kapizioni","year":"2024","journal-title":"J Crohns Colitis"},{"key":"2026081219452678000_jjag121-B8","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s00535-016-1266-1","article-title":"Cost-effectiveness of drug monitoring of anti-TNF therapy in inflammatory bowel disease and rheumatoid arthritis: a systematic review","volume":"52","author":"Martelli","year":"2017","journal-title":"J Gastroenterol"},{"key":"2026081219452678000_jjag121-B9","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1016\/S2468-1253(20)30012-1","article-title":"Health-care costs of inflammatory bowel disease in a pan-European, community-based, inception cohort during 5 years of follow-up: a population-based study","volume":"5","author":"Burisch","year":"2020","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"2026081219452678000_jjag121-B10","doi-asserted-by":"publisher","first-page":"e001225","DOI":"10.1136\/bmjgast-2023-001225","article-title":"Biological therapy for inflammatory bowel disease: cyclical rather than lifelong treatment?","volume":"11","author":"Selinger","year":"2024","journal-title":"BMJ Open Gastroenterol"},{"key":"2026081219452678000_jjag121-B11","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1111\/apt.13276","article-title":"Systematic review: factors associated with relapse of inflammatory bowel disease after discontinuation of anti-TNF therapy","volume":"42","author":"Gisbert","year":"2015","journal-title":"Aliment Pharmacol Ther"},{"key":"2026081219452678000_jjag121-B12","doi-asserted-by":"publisher","DOI":"10.1093\/ecco-jcc\/jjag110","article-title":"Anti-TNF withdrawal or long-term treatment in ulcerative colitis (BIOSTOP): a multicentre open label, randomized controlled trial","author":"Berset","journal-title":"J Crohn's Colitis"},{"key":"2026081219452678000_jjag121-B13","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/S2468-1253(21)00062-5","article-title":"Discontinuation of infliximab in patients with ulcerative colitis in remission (HAYABUSA): a multicentre, open-label, randomised controlled trial","volume":"6","author":"Kobayashi","year":"2021","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"2026081219452678000_jjag121-B14","doi-asserted-by":"publisher","first-page":"EVIDoa2200061","DOI":"10.1056\/EVIDoa2200061","article-title":"Discontinuation of infliximab therapy in patients with Crohn\u2019s disease","volume":"1","author":"Buhl","year":"2022","journal-title":"NEJM Evid"},{"key":"2026081219452678000_jjag121-B15","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1186\/s12876-022-02522-4","article-title":"Prediction of long-term remission in patients following discontinuation of anti-TNF therapy in ulcerative colitis: a 10 year follow up study","volume":"22","author":"Johnsen","year":"2022","journal-title":"BMC Gastroenterol"},{"key":"2026081219452678000_jjag121-B16","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1136\/gutjnl-2024-333385","article-title":"Withdrawal of antitumour necrosis factor in inflammatory bowel disease patients in remission: a randomised placebo-controlled clinical trial of GETECCU","volume":"74","author":"Gisbert","year":"2025","journal-title":"Gut"},{"key":"2026081219452678000_jjag121-B17","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/S2468-1253(22)00385-5","article-title":"Withdrawal of infliximab or concomitant immunosuppressant therapy in patients with Crohn\u2019s disease on combination therapy (SPARE): a multicentre, open-label, randomised controlled trial","volume":"8","author":"Louis","year":"2023","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"2026081219452678000_jjag121-B18","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1136\/gutjnl-2015-310393","article-title":"Development and validation of a histological index for UC","volume":"66","author":"Mosli","year":"2017","journal-title":"Gut"},{"key":"2026081219452678000_jjag121-B19","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1038\/s41587-020-0439-x","article-title":"The nf-core framework for community-curated bioinformatics pipelines","volume":"38","author":"Ewels","year":"2020","journal-title":"Nat Biotechnol"},{"key":"2026081219452678000_jjag121-B20","unstructured":"Krueger F, James F, Ewels P, et al \u00a0FelixKrueger\/TrimGalore: v0.6.10 - add default decompression path [Internet]. Zenodo; 2023. Cited August 18, 2025. https:\/\/zenodo.org\/record\/7598955, 10.5281\/ZENODO.7598955"},{"key":"2026081219452678000_jjag121-B21","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","article-title":"STAR: ultrafast universal RNA-seq aligner","volume":"29","author":"Dobin","year":"2013","journal-title":"Bioinformatics"},{"key":"2026081219452678000_jjag121-B22","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1038\/nmeth.4197","article-title":"Salmon provides fast and bias-aware quantification of transcript expression","volume":"14","author":"Patro","year":"2017","journal-title":"Nat Methods"},{"key":"2026081219452678000_jjag121-B23","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2","volume":"15","author":"Love","year":"2014","journal-title":"Genome Biol"},{"key":"2026081219452678000_jjag121-B24","doi-asserted-by":"publisher","first-page":"2084","DOI":"10.1093\/bioinformatics\/bty895","article-title":"Heavy-tailed prior distributions for sequence count data: removing the noise and preserving large differences","volume":"35","author":"Zhu","year":"2019","journal-title":"Bioinformatics"},{"key":"2026081219452678000_jjag121-B25","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1089\/omi.2011.0118","article-title":"clusterProfiler: an R package for comparing biological themes among gene clusters","volume":"16","author":"Yu","year":"2012","journal-title":"OMICS"},{"key":"2026081219452678000_jjag121-B26","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/nar\/28.1.27","article-title":"KEGG: Kyoto Encyclopedia Of Genes And Genomes","volume":"28","author":"Kanehisa","year":"2000","journal-title":"Nucleic Acids Res"},{"key":"2026081219452678000_jjag121-B27","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/75556","article-title":"Gene Ontology: tool for the unification of biology","volume":"25","author":"Ashburner","year":"2000","journal-title":"Nat Genet"},{"key":"2026081219452678000_jjag121-B28","doi-asserted-by":"publisher","first-page":"D1779","DOI":"10.1093\/nar\/gkaf1292","article-title":"The Gene Ontology knowledgebase in 2026","volume":"54","author":"Aleksander","year":"2026","journal-title":"Nucleic Acids Res"},{"key":"2026081219452678000_jjag121-B29","doi-asserted-by":"publisher","first-page":"D672","DOI":"10.1093\/nar\/gkad1025","article-title":"The reactome pathway knowledgebase 2024","volume":"52","author":"Milacic","year":"2024","journal-title":"Nucleic Acids Res"},{"key":"2026081219452678000_jjag121-B30","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s13059-026-03955-w","article-title":"omnideconv: a unifying framework for using and benchmarking single-cell-informed deconvolution of bulk RNA-seq data","volume":"27","author":"Dietrich","year":"2026","journal-title":"Genome Biol"},{"key":"2026081219452678000_jjag121-B31","doi-asserted-by":"publisher","first-page":"2152","DOI":"10.1038\/s41590-024-01994-8","article-title":"A longitudinal single-cell atlas of anti-tumour necrosis factor treatment in inflammatory bowel disease","volume":"25","author":"Thomas","year":"2024","journal-title":"Nat Immunol"},{"key":"2026081219452678000_jjag121-B32","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s13059-017-1382-0","article-title":"SCANPY: large-scale single-cell gene expression data analysis","volume":"19","author":"Wolf","year":"2018","journal-title":"Genome Biol"},{"key":"2026081219452678000_jjag121-B33","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1038\/s41587-023-01767-y","article-title":"Dictionary learning for integrative, multimodal and scalable single-cell analysis","volume":"42","author":"Hao","year":"2024","journal-title":"Nat Biotechnol"},{"key":"2026081219452678000_jjag121-B34","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1038\/s41576-023-00586-w","article-title":"Best practices for single-cell analysis across modalities","volume":"24","author":"Heumos","year":"2023","journal-title":"Nat Rev Genet"},{"key":"2026081219452678000_jjag121-B35","doi-asserted-by":"publisher","first-page":"2975","DOI":"10.1038\/s41467-019-10802-z","article-title":"Accurate estimation of cell-type composition from gene expression data","volume":"10","author":"Tsoucas","year":"2019","journal-title":"Nat Commun"},{"key":"2026081219452678000_jjag121-B36","doi-asserted-by":"publisher","first-page":"1970","DOI":"10.1038\/s41591-021-01520-5","article-title":"IL-1-driven stromal\u2013neutrophil interactions define a subset of patients with inflammatory bowel disease that does not respond to therapies","volume":"27","author":"Friedrich","year":"2021","journal-title":"Nat Med"},{"key":"2026081219452678000_jjag121-B37","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1080\/00365520701409035","article-title":"Tissue levels of tumor necrosis factor-alpha correlates with grade of inflammation in untreated ulcerative colitis","volume":"42","author":"Olsen","year":"2007","journal-title":"Scand J Gastroenterol"},{"key":"2026081219452678000_jjag121-B38","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1053\/j.gastro.2024.10.001","article-title":"AGA living clinical practice guideline on pharmacological management of moderate-to-severe ulcerative colitis","volume":"167","author":"Singh","year":"2024","journal-title":"Gastroenterology"},{"key":"2026081219452678000_jjag121-B39","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1056\/NEJMoa2314076","article-title":"Phase 2 trial of anti-TL1A monoclonal antibody tulisokibart for ulcerative colitis","volume":"391","author":"Sands","year":"2024","journal-title":"N Engl J Med"},{"key":"2026081219452678000_jjag121-B40","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1038\/s41591-022-01680-y","article-title":"Ulcerative colitis is characterized by a plasmablast-skewed humoral response associated with disease activity","volume":"28","author":"Uzzan","year":"2022","journal-title":"Nat Med"},{"key":"2026081219452678000_jjag121-B41","author":"Brandtzaeg","year":"2006"},{"key":"2026081219452678000_jjag121-B42","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1056\/NEJMc2508023","article-title":"CD19 CAR T-cell therapy in multidrug-resistant ulcerative colitis","volume":"393","author":"M\u00fcller","year":"2025","journal-title":"N Engl J Med"},{"key":"2026081219452678000_jjag121-B43","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1016\/j.cell.2019.06.029","article-title":"Intra- and inter-cellular rewiring of the human colon during ulcerative colitis","volume":"178","author":"Smillie","year":"2019","journal-title":"Cell"},{"key":"2026081219452678000_jjag121-B44","doi-asserted-by":"publisher","first-page":"611256","DOI":"10.3389\/fimmu.2021.611256","article-title":"The IL23-IL17 immune axis in the treatment of ulcerative colitis: successes, defeats, and ongoing challenges","volume":"12","author":"Noviello","year":"2021","journal-title":"Front Immunol"},{"key":"2026081219452678000_jjag121-B45","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.1136\/gutjnl-2011-301668","article-title":"Secukinumab, a human anti-IL-17A monoclonal antibody, for moderate to severe Crohn\u2019s disease: unexpected results of a randomised, double-blind placebo-controlled trial","volume":"61","author":"Hueber","year":"2012","journal-title":"Gut"}],"container-title":["Journal of Crohn's and Colitis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ecco-jcc\/article-pdf\/20\/8\/jjag121\/70621659\/jjag121.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ecco-jcc\/article-pdf\/20\/8\/jjag121\/70621659\/jjag121.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T23:45:32Z","timestamp":1786578332000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ecco-jcc\/article\/doi\/10.1093\/ecco-jcc\/jjag121\/8759949"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":45,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8,5]]}},"URL":"https:\/\/doi.org\/10.1093\/ecco-jcc\/jjag121","relation":{},"ISSN":["1873-9946","1876-4479"],"issn-type":[{"value":"1873-9946","type":"print"},{"value":"1876-4479","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,8]]},"published":{"date-parts":[[2026,8]]},"article-number":"jjag121"}}